No Data
No Data
Catalyst Watch: FOMC Meeting, Govt. Funding Drama, Earnings for Micron, Nike, and FedEx
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Cellectar Biosciences Plunges on Pursuit of Strategic Options for Cancer Drug Candidate, 60% Workforce Cut
Cellectar Biosciences Cut to Perform From Outperform by Oppenheimer
Cellectar Biosciences Analyst Ratings
Nasdaq Surges Over 1%; US Inflation Rises In-Line With Expectations